Abbvie Inc
NYSE:ABBV
Abbvie Inc
NYSE:ABBV
Price:
164.66 USD
0.25%
Market Closed
Updated:
Apr 19, 2024
Abbvie Inc
Other Assets
Last
Value
3-Years CAGR
5-Years CAGR
|
Abbvie Inc
Other Assets Peer Comparison
Comparables:
GILD
AMGN
VRTX
REGN
SGEN
Competitive Other Assets Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Abbvie Inc
NYSE:ABBV
|
Other Assets
$32.3B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
16%
|
CAGR 10-Years
18%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Assets
$8.3B
|
CAGR 3-Years
1%
|
CAGR 5-Years
15%
|
CAGR 10-Years
22%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Assets
$18.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
2%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Assets
$1.1B
|
CAGR 3-Years
3%
|
CAGR 5-Years
85%
|
CAGR 10-Years
43%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Seagen Inc
NASDAQ:SGEN
|
Other Assets
$274.7m
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
See Also
What is Abbvie Inc's Other Assets?
Other Assets
32.3B
USD
32.3B
USD
Based on the financial report for Dec 31, 2023, Abbvie Inc's Other Assets amounts to 32.3B USD.
What is Abbvie Inc's Other Assets growth rate?
Other Assets CAGR 10Y
18%
18%
Over the last year, the Other Assets growth was 0%. The average annual Other Assets growth rates for Abbvie Inc have been -1% over the past three years , 16% over the past five years , and 18% over the past ten years .
You don't have any saved screeners yet
